|1.||Liu, Lin: 2 articles (01/2015 - 06/2011)|
|2.||Li, Jia-Rui: 2 articles (01/2015 - 01/2014)|
|3.||Lou, Li-Guang: 2 articles (01/2014 - 08/2012)|
|4.||Huang, Xin-En: 2 articles (01/2013 - 01/2013)|
|5.||Xiang, Jin: 2 articles (01/2013 - 01/2013)|
|6.||Lu, Yan-Yan: 2 articles (01/2013 - 01/2013)|
|7.||Peng, Wenwen: 1 article (11/2015)|
|8.||Yang, Yan: 1 article (11/2015)|
|9.||Gu, Jingkai: 1 article (11/2015)|
|10.||Gao, Jingyi: 1 article (11/2015)|
09/01/1999 - "The purpose of this study was to determine the influence of impaired renal and liver function on the pharmacokinetics and pharmacodynamics of lobaplatin in cancer patients. "
04/01/2014 - "These results indicate that lobaplatin could be an effective chemotherapeutic agent in human cervical cancer treatment by inducing apoptosis, cell cycle arrest and changing many kinds of protein molecule expression level. "
04/01/2014 - "Lobaplatin showed a good antitumour activity in in vitro models of human cervical cancer cells. "
04/01/2014 - "Flow cytometry assay confirmed that lobaplatin affected cervical cancer cell survival by blocking cell cycle progression in S phase and G0/G1 phase and inducing apoptosis in dose- and time-dependent manner. "
04/01/2014 - "Our findings have shown that lobaplatin inhibits cell proliferations in human cervical cancer CaSki cells in dose- and time-dependent manner. "
|2.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2014 - "However, the efficacy of lobaplatin in ovarian cancer has not been systemically evaluated. "
06/01/1995 - "A phase II trial with lobaplatin was performed in patients with refractory or relapsed ovarian cancer to define activity and pharmacokinetics. "
06/01/1995 - "Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer."
01/01/2003 - "Lobaplatin has also completed phase II clinical trials in the US, Australia, EU, Brazil and South Africa for the treatment of various cancers, including breast, oesophageal, lung and ovarian cancers as well as CML."
07/01/1995 - "A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer."
|3.||Esophageal Neoplasms (Esophageal Cancer)
10/01/2015 - "Lobaplatin-paclitaxel showed a significant antitumor effect to squamous esophageal cancer with manageable toxicities. "
04/01/1997 - "Since lobaplatin has activity in esophageal cancer, combination protocols with 5-fluorouracil (5-FU) are evaluated. "
01/01/2015 - "Lobaplatin plus 5-Fu combined with concurrent radiotherapy is safe and effective in treating patients with middle-advanced stage esophageal cancer. "
01/01/2015 - "Clinical Study on Lobaplatin Combined with 5-Fu and Concurrent Radiotherapy in Treating Patients with Inoperable Esophageal Cancer."
10/01/2015 - "To assess the efficacy and toxicities of combined lobaplatin with paclitaxel (LP) as a first line chemotherapy in esophageal cancer. "
|4.||Osteosarcoma (Osteogenic Sarcoma)
09/01/2002 - "The aim of this study was to evaluate the clinical and hematological side-effects and to assess the efficacy of lobaplatin chemotherapy in dogs with appendicular osteosarcoma as an adjuvant therapy to surgical resection. "
09/01/2002 - "Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation."
|5.||Malignant Pleural Effusion
01/01/2013 - "Lobaplatin (20-30 mg/m2) was intrapleurally or intraperitoneally infused for patients with malignant pleural effusion or ascites. "
01/01/2013 - "Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites."
01/01/2013 - "Intrapleural or intraperitoneal infusion of lobaplatin is a safe treatment for patients with malignant pleural effusion or ascites, and the treatment efficacy is encouraging."
01/01/2013 - "From 2012 to 2013, intrapleural or intraperitonea lobaplatin was administered for patients with colorectal or uterus cancer who were previous treated for malignant pleural effusion or ascites. "
|3.||Ethiodized Oil (Ethiodol)
|9.||Vinblastine (Vinblastine Sulfate)
|1.||Drug Therapy (Chemotherapy)
|4.||Heterologous Transplantation (Xenotransplantation)